Biography

Dr. Lieber is originally from New Jersey and received her medical training at the University of Michigan in Ann Arbor. She completed her internal medicine residency at the Icahn School of Medicine at Mount Sinai in New York, and then pursued advanced training with fellowships in gastroenterology and transplant hepatology at the University of North Carolina in Chapel Hill. There she also completed a Master in Science in Clinical Research from the Department of Epidemiology at the Gillings School of Public Health. She joined UT Southwestern as a faculty member in 2020 in the Division of Digestive and Liver Disease. Dr. Lieber brings to UT Southwestern a strong background in advanced liver disease, clinical research, and ethics. In 2018, she received the American Association for the Study of Liver Disease (AASLD) Innovation Award followed by the AASLD Advanced/Transplant Hepatology Award in 2019. Her clinical practice emphasizes patient-centered care for individuals with advanced liver disease in need of liver transplantation. Her research interests are focused in survivorship after liver transplantation, patient reported outcomes, and health behavior intervention implementation. Dr. Lieber’s interests outside of medicine include spending time with her family, dogs, cooking, cycling, and traveling.

Education

Medical School
University of Michigan Medical School (2013)
Residency
Mount Sinai Medical Center (2016), Internal Medicine
Graduate School
Gillings School of Public Health - University of North Carolina (2019)
Fellowship
University of North Carolina Chapel Hill (2019), Gastroenterology
Fellowship
University of North Carolina Chapel Hill (2020), Transplant Hepatology

Research Interest

  • Health Behavior Intervention Adaptation and Implementation
  • Liver Transplantation Outcomes
  • Patient-reported Outcomes in Advanced Liver Disease and Liver Transplantation
  • Survivorship after Liver Transplantation

Publications

Featured Publications LegendFeatured Publications

Monitoring Cardiovascular Risks Factors After Liver Transplantation May Improve Outcomes.
VanWagner LB, Lieber SR, Liver Transpl 2022 Apr
The Practice of Retransplantation for Recurrent Alcohol-associated Liver Disease in the United States Is Uncommon With Acceptable Outcomes.
Cotter TG, Odenwald MA, Lieber SR, Rich NE, Im G, Charlton M, Singal AG, Mitchell MC, Transplant Direct 2022 Mar 8 3 e1297
Systematic review and meta-analysis: incidence of variceal hemorrhage in patients with cirrhosis undergoing transesophageal echocardiography.
Odewole M, Sen A, Okoruwa E, Lieber SR, Cotter TG, Nguyen AD, Mufti A, Singal AG, Rich NE, Aliment Pharmacol Ther 2022 Mar
"Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era.
Cotter TG, Wang J, Lieber SR, Odenwald MA, Rich NE, Marrero JA, Singal AG, Mitchell MC, Aronsohn A, Charlton M, Fung J, Transplant Direct 2021 Jul 7 7 e707
Antiplatelet Medications Are Associated With Bleeding and Decompensation Events Among Patients With Cirrhosis.
Lieber SR, Jiang Y, Moon A, Barritt AS, J Clin Gastroenterol 2021 May

Books

Featured Books Legend Featured Books

Honors & Awards

  • AASLD Advanced/Transplant Hepatology Award
    American Association for the Study of Liver Diseases (2019-2021)
  • Alpha Omega Alpha
    Medical Honor Society (2019)
  • AASLD Innovation Fund
    American Association for the Study of Liver Diseases (2018-2020)

Professional Associations/Affiliations

  • American Society for Transplantation (2020)
  • AGA Institute Ethics Committee (2019-2021)
  • European Association for Study of Liver Disease (2017)
  • American Gastroenterology Association (2016)
  • American Association for the Study of Liver Diseases (2015)